About
This forum is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in cytokine signalling. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of cytokines and cytokine signalling, and its implications for clinical practice.
The programmes are free from commercial bias, and feature leading experts sharing their knowledge and experience in the form of video tutorials.
Publications
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
Publications
Risankizumab for Ulcerative Colitis Two Randomized Clinical Trials
Publications
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
Publications
Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib
Podcasts
Discussing AxSpA: Incidence of uveitis following bimekizumab treatment
Publications
Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two Phase III studies
Podcasts
Author Interview: Professor Laura Andreoli, 2024
Publications
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis: A single-centre retrospective analysis
Publications
Enhanced type 1 interferon signature in axial spondyloarthritis patients unresponsive to secukinumab treatment
Podcasts
Discussing RA: Neutrophil-to-lymphocyte ratio and treatment response to filgotinib
Publications
A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment
Publications
Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
Podcasts
Author Interview: Dr Adam Goldman, 2024
Publications
Effects of mirikizumab on histologic resolution of Crohn's sisease in a randomised controlled Phase 2 trial
Publications
Efficacy and safety of etrasimod in patients with moderately to severely active isolated proctitis: Results from the Phase 3 ELEVATE UC clinical programme
Publications
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Publications
Efficacy and Safety of Bimekizumab in Patients with Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies
Publications
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study
Publications
Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial
Podcasts
Author Interview: Professor Daniel Blockmans, 2024
Podcasts
Discussing PsA: Guselkumab and analysis of genetic markers
Publications
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study
Podcasts
Discussing RA: July 2024
Publications
Pregnancy outcomes in patients treated with upadacitinib: Analysis of data from clinical trials and postmarketing reports
Publications
Risankizumab induction therapy achieves early symptom improvements that are associated with future clinical and endoscopic outcomes in Crohn's disease: Post hoc analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 studies
Publications
Efficacy and safety of filgotinib for the treatment of perianal fistulising Crohn’s disease [DIVERGENCE 2]: A Phase 2, randomised, placebo-controlled trial
Publications
Patients with high baseline neutrophil-to-lymphocyte ratio exhibit better response to filgotinib as treatment for rheumatoid arthritis
Publications
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: Pooled results from Phase 2b/3 trials
Publications
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of Phase 2/3 randomized trials
Publications
Tofacitinib in acute severe ulcerative colitis (TACOS): A randomized controlled trial
Publications
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)
Podcasts